Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Dec 13:12:e18308.
doi: 10.7717/peerj.18308. eCollection 2024.

The association between fibroblast growth factor 21 with diabetes retinopathy among type 2 diabetes mellitus patients: a systematic review, meta-analysis, and meta-regression

Herni Basir  1 , Annisa Salsabilla Dwi Nugrahani  2 , Andi Makbul Aman  1 , Syakib Bakri  3 , Haerani Rasyid  3 , Husaini Umar  1 , Faridin H P  3 , Andi Muhammad Ichsan  4 , Andi Alfian Zainuddin  5
Affiliations
Meta-Analysis

The association between fibroblast growth factor 21 with diabetes retinopathy among type 2 diabetes mellitus patients: a systematic review, meta-analysis, and meta-regression

Herni Basir et al. PeerJ. .

Abstract

Background: Diabetic retinopathy (DR), a leading cause of vision loss worldwide, is a common complication of type 2 diabetes mellitus (T2DM) driven by chronic hyperglycemia and microvascular damage. Fibroblast growth factor 21 (FGF21) is crucial in blood sugar regulation and has been linked to DR incidence and severity. While some studies suggest that FGF21 levels may contribute to the DR incidence, others propose a protective role. This discrepancy necessitates further analysis, prompting this study to evaluate the association between FGF21 levels and DR incidence and severity in T2DM patients.

Methods: A systematic search was conducted through MEDLINE, Web of Science, Scopus, and Embase up to May 2024 for studies evaluating the association between FGF21 and DR incidence and severity. A random-effect model meta-analysis was performed to calculate the pooled standardized mean difference (SMD) and 95% confidence intervals (CI). A univariate meta-regression was performed to analyze factors influencing pooled size estimates. All statistical analyses were performed using STATA 17 software.

Result: This systematic review and meta-analysis of 5,852 participants revealed that FGF21 was positively correlated with DR (SMD 3.11; 95% CI [0.92-5.30], p = 0.005) and sight-threatening DR (STDR) incidence (SMD 3.61; 95% CI [0.82-6.41], p = 0.01). There was no significant difference in FGF21 levels in DR vs STDR (p = 0.79). Subgroup analysis revealed a significant difference in DR incidence between LDL groups, with higher DR incidence in the group with low-density lipoprotein (LDL) levels >100 (P < 0.00001). Meta-regression revealed no variables significantly influenced the pooled size estimates.

Conclusion: A higher level of FGF21 was associated with higher DR and STDR incidence among T2DM patients, highlighting its potential utilization as a biomarker for DR detection and enabling the exploration of FGF21-based treatment strategies. However, variables independently predicting DR among patients with elevated FGF21 levels shall be explored further.

Prospero id: CRD42024559142.

Keywords: Diabetic retinopathy; Fibroblast growth factor; Meta-analysis; Meta-regression; Type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1. PRISMA flow diagram of the included studies.
Figure 2
Figure 2. Association between FGF-21 levels with DR incidence (Jin, Xia & Han, 2021; Lin et al., 2014; Esteghamati et al., 2016; Heidari & Hasanpour, 2021; Mousavi et al., 2017).
Figure 3
Figure 3. Association between FGF-21 levels with STDR incidence (Jin, Xia & Han, 2021; Lin et al., 2014; Heidari & Hasanpour, 2021; Mousavi et al., 2017).
Figure 4
Figure 4. Association between FGF-21 levels with DR severity (Jin, Xia & Han, 2021; Lin et al., 2014; Esteghamati et al., 2016; Heidari & Hasanpour, 2021; Mousavi et al., 2017).
Figure 5
Figure 5. Summary of subgroup analysis.
Figure 6
Figure 6. Sensitivity analysis (Jin, Xia & Han, 2021; Lin et al., 2014; Esteghamati et al., 2016; Heidari & Hasanpour, 2021; Mousavi et al., 2017).
Figure 7
Figure 7. Funnel plot.
See this image and copyright information in PMC

References

    1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Supplement_1):S81–S90. doi: 10.2337/dc14-S081. - DOI - PubMed
    1. American Diabetes Association 11. Microvascular complications and foot care: standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Supplement_1):S151–S167. doi: 10.2337/dc21-S011. - DOI - PubMed
    1. Ansari P, Tabasumma N, Snigdha NN, Siam NH, Panduru RVNRS, Azam S, Hannan JMA, Abdel-Wahab YHA. Diabetic retinopathy: an overview on mechanisms. Pathophysiology and Pharmacotherapy, Diabetology. 2022;3(1):159–175. doi: 10.3390/diabetology3010011. - DOI
    1. Brownlee M. The pathobiology of diabetic complications. Diabetes. 2005;54(6):1615–1625. doi: 10.2337/diabetes.54.6.1615. - DOI - PubMed
    1. Brydges CR. Effect size guidelines, sample size calculations, and statistical power in gerontology. Innovation in Aging. 2019;3(4):713. doi: 10.1093/geroni/igz036. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources